Home » Newsletters » BioWorld Science

BioWorld Science

July 24, 2013

View Archived Issues

ASP-1017FM has potentially beneficial effects on migraine

Hanmi Science discloses new protein kinase inhibitors for cancer

Pulmatrix commences phase Ib COPD study

Novel agents for metabolic diseases disclosed by Cadila Healthcare

Genmab submits IND to conduct phase I study of HuMax-TF-ADC

Gilead Sciences presents novel agents for HIV infection

Researchers at Rutgers disclose new antibacterial RNA polymerase inhibitors

Daiichi Sankyo and Ube Industries synthesize new CETP inhibitors

Experiments profile preclinical activity of Alzheimer's disease candidate AZD-3293

Novel drug and drug target for the treatment of addictive disorders characterized

Noven Pharmaceuticals reports topline results from phase II d-ATS

Results of a phase I evaluation of antigen-specific tolerance for multiple sclerosis

Ligand signs license agreement with Azure Biotech for lasofoxifene

New biomaterial coatings to improve bone-bioimplant interface stability

Cellular Biomedicine begins phase I trial of adipose-derived mesenchymal progenitor cells

Johnson & Johnson reviews second quarter 2013

Aquinox begins dosing in phase II trial of AQX-1125 in BPS/IC

Protalex continues enrollment in phase Ib trial of PRTX-100 following third interim review

Mast Therapeutics' QT study of MST-188 meets primary endpoint

Charleston Laboratories completes pre-IND meeting regarding migraine treatment

Phase III trial comparing obinutuzumab to Rituxan in CLL meets primary endpoint

Arrowhead commences phase I trial of RNAi therapeutic

Quest PharmaTech and AD Biotech form joint venture

Trovagene's reports validation of assay for detecting BRAF mutation in urine

Roche launches new drug monitoring tests for immunosuppressive therapies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...